Policies that address COVID-19 prevention, treatment, and pandemic relief must consider sex as a biological variable as well as the influence of social determinants of health, including gender.
SWHR supports efforts that improve the representation of women and other historically underrepresented groups within all levels of the biomedical workforce.
Sex and gender, race and ethnicity, identity, faith, disability status, pregnancy, socioeconomic status, incarceration, and immigration status should not impede an individual’s ability to access or receive quality health care.
The federal government must support research that addresses the unique health needs of women across the lifespan. SWHR recommends continued robust funding for major federal agencies that support women’s health research.
Research must take into account sex as a biological variable (SABV) in order to better understand its impact on health and disease. SWHR supports studying, analyzing, and reporting on biological sex as standard practice across all research.
In line with our mission to ensure women’s participation in biomedical research, SWHR strongly supports appropriate inclusion of pregnant and lactating women in clinical research.
